Central Serous Chorioretinopathy: Etiology, Course and Prognosis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01378130 |
Recruitment Status :
Completed
First Posted : June 22, 2011
Last Update Posted : April 26, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Central Serous Chorioretinopathy |
Study Type : | Observational |
Actual Enrollment : | 50 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Central Serous Chorioretinopathy: An Observational Study About Etiology, Course and Prognosis |
Study Start Date : | April 2011 |
Actual Primary Completion Date : | April 2013 |
Actual Study Completion Date : | April 2013 |

- Clinical Outcome [ Time Frame: 2 years ]OCT, Visus
- Subclinical Data [ Time Frame: 2 years ]FA findings, retinal sensitivity in Microperimetry, contrast sensitivity, Amsler Grid Test

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Signed informed consent form
- Age over 18 years
- acute episode of Central Serous Chorioretinopathy
- Symptoms for less than two weeks
- no treatment on study eye
Exclusion Criteria:
- bad compliance
- protected patient group (pregnant women)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01378130
Austria | |
Vienna Gerenal Hospital | |
Vienna, Austria |
Principal Investigator: | Stefan Sacu, Ass.Prof.Dr. | Department of Ophthalmology, Medical University of Vienna, Austria |
Responsible Party: | Stefan Sacu, Assoc. Prof. Dr., Medical University of Vienna |
ClinicalTrials.gov Identifier: | NCT01378130 |
Other Study ID Numbers: |
EK 180/2011 |
First Posted: | June 22, 2011 Key Record Dates |
Last Update Posted: | April 26, 2013 |
Last Verified: | April 2013 |
CCS CSC Subretinal Fluid multimodal imaging |
Central Serous Chorioretinopathy Retinal Diseases Eye Diseases |